Analytical Data
-
Gene name
FGF13
- Application
-
Alternative Names
FGF13；FHF2；Fibroblast growth factor 13
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q92913
-
Expression Region
1-245aa
-
AA Sequence
MAAAIASSLI RQKRQARERE KSNACKCVSS PSKGKTSCDK NKLNVFSRVK LFGSKKRRRR RPEPQLKGIV TKLYSRQGYH LQLQADGTID GTKDEDSTYT LFNLIPVGLR VVAIQGVQTK LYLAMNSEGY LYTSELFTPE CKFKESVFEN YYVTYSSMIY RQQQSGRGWY LGLNKEGEIM KGNHVKKNKP AAHFLPKPLK VAMYKEPSLH DLTEFSRSGS GTPTKSRSVS GVLNGGKSMS HNEST
-
Molecular Weight
28 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fibroblast growth factor 13 (FGF13) is a member of the fibroblast growth factor family, which plays crucial roles in various biological processes, including cell proliferation, differentiation, and survival. Unlike other FGFs, FGF13 is primarily expressed in the brain and heart, where it has been implicated in neuronal development and cardiac function. Recent studies have highlighted its potential involvement in neuroprotective mechanisms and cardiac arrhythmias, making it a significant focus for research in neurobiology and cardiology. The recombinant production of FGF13 proteins is essential for elucidating their structural and functional properties, as well as for exploring their therapeutic potential. Understanding how FGF13 interacts with its receptors and other cellular pathways is vital for developing strategies to mitigate diseases linked to its dysfunction, such as neurodegenerative disorders and heart diseases. Therefore, generating purified FGF13 recombinant proteins is a critical step toward advancing our understanding of its biological roles and therapeutic applications.
